BAX and ovarian carcinoma: Current knowledge of ovarian cancer provides strong indications that not only establish BOK as an inducer of apoptosis in a BAX- and BAK1-independent manner, but also suggest that BOK can significantly influence the apoptotic response to chemotherapeutic drugs in ovarian carcinoma cells [12].